These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Lesch-Nyhan syndrome: evidence for abnormal adrenergic function. Rockson S, Stone R, Van der Weyden M, Kelley WN. Science; 1974 Dec 06; 186(4167):934-5. PubMed ID: 4469689 [Abstract] [Full Text] [Related]
7. Abnormalities in cellular adhesion of neuroblastoma and fibroblast models of Lesch Nyhan syndrome. Stacey NC, Ma MH, Duley JA, Connolly GP. Neuroscience; 2000 Dec 06; 98(2):397-401. PubMed ID: 10854773 [Abstract] [Full Text] [Related]
9. [Lesch-Nyhan syndrome with total deficiency of the enzyme hypoxanthine phosphoribosyltransferase]. Pascual-Castroviejo I, Vélez A, García Puig J, López Jiménez M. Neurologia; 1986 Dec 06; 1(1):44-5. PubMed ID: 3274108 [No Abstract] [Full Text] [Related]
12. Monoamine oxidase activity in normal and Lesch-Nyhan fibroblasts. Edelstein SB, Castiglione CM, Breakfield XO. J Neurochem; 1978 Nov 06; 31(5):1247-54. PubMed ID: 702170 [No Abstract] [Full Text] [Related]
13. Eighteen novel mutations in patients with Lesch-Nyhan syndrome or partial hypoxanthine phosphoribosyltransferase deficiency. Willers I, Bolz H, Wehnert M, Gal A. J Inherit Metab Dis; 1999 Oct 06; 22(7):845-6. PubMed ID: 10518289 [No Abstract] [Full Text] [Related]
15. Phosphoribosylpyrophosphate overproduction, a new metabolic abnormality in the Lesch Nyhan syndrome. Reem GH. Science; 1975 Dec 12; 190(4219):1098-9. PubMed ID: 171772 [Abstract] [Full Text] [Related]
16. Properties of monoamine oxidase in control and Lesch-Nyhan fibroblasts. Castro Costa MR, Edelstein SB, Castiglione CM, Chao H, Breakefield XO. Biochem Genet; 1980 Jun 12; 18(5-6):577-90. PubMed ID: 7437013 [Abstract] [Full Text] [Related]